BlackRock’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2B | Buy |
48,849,973
+1,227,343
| +3% | +$28.4M | 0.02% | 664 |
|
|
2026
Q1 | $1.14B | Buy |
47,622,630
+1,287,233
| +3% | +$31.5M | 0.02% | 626 |
|
|
2025
Q4 | $1.05B | Buy |
46,335,397
+156,895
| +0.3% | +$3.41M | 0.02% | 661 |
|
|
2025
Q3 | $930M | Buy |
46,178,502
+23,107,031
| +100% | +$387M | 0.02% | 702 |
|
|
2025
Q2 | $329M | Sell |
23,071,471
-644,373
| -3% | -$7.53M | 0.01% | 1308 |
|
|
2025
Q1 | $249M | Sell |
23,715,844
-1,151,724
| -5% | -$13M | 0.01% | 1477 |
|
|
2024
Q4 | $301M | Buy |
24,867,568
+566,155
| +2% | +$7.41M | 0.01% | 1417 |
|
|
2024
Q3 | $357M | Buy |
24,301,413
+1,000,256
| +4% | +$13.9M | 0.01% | 1310 |
|
|
2024
Q2 | $336M | Sell |
23,301,157
-3,338,626
| -13% | -$53.3M | 0.01% | 1271 |
|
|
2024
Q1 | $434M | Sell |
26,639,783
-1,143,772
| -4% | -$17.9M | 0.01% | 1138 |
|
|
2023
Q4 | $414M | Buy |
27,783,555
+664,483
| +2% | +$7.53M | 0.01% | 1142 |
|
|
2023
Q3 | $305M | Sell |
27,119,072
-37,317
| -0.1% | -$433K | 0.01% | 1264 |
|
|
2023
Q2 | $273M | Sell |
27,156,389
-1,904,047
| -7% | -$17.7M | 0.01% | 1359 |
|
|
2023
Q1 | $273M | Sell |
29,060,436
-20,374
| -0.1% | -$240K | 0.01% | 1324 |
|
|
2022
Q4 | $355M | Buy |
29,080,810
+1,309,981
| +5% | +$16.3M | 0.01% | 1119 |
|
|
2022
Q3 | $345M | Sell |
27,770,829
-536,379
| -2% | -$9.38M | 0.01% | 1072 |
|
|
2022
Q2 | $556M | Buy |
28,307,208
+2,089,291
| +8% | +$49.5M | 0.02% | 778 |
|
|
2022
Q1 | $684M | Buy |
26,217,917
+1,631,045
| +7% | +$43.4M | 0.02% | 761 |
|
|
2021
Q4 | $698M | Buy |
24,586,872
+548,577
| +2% | +$17.1M | 0.02% | 782 |
|
|
2021
Q3 | $767M | Sell |
24,038,295
-1,755,114
| -7% | -$58.9M | 0.02% | 701 |
|
|
2021
Q2 | $895M | Sell |
25,793,409
-3,607,314
| -12% | -$119M | 0.02% | 647 |
|
|
2021
Q1 | $866M | Buy |
29,400,723
+2,242,381
| +8% | +$69M | 0.03% | 658 |
|
|
2020
Q4 | $833M | Buy |
27,158,342
+5,199,820
| +24% | +$159M | 0.03% | 606 |
|
|
2020
Q3 | $613M | Sell |
21,958,522
-3,727,223
| -15% | -$94.5M | 0.02% | 642 |
|
|
2020
Q2 | $551M | Buy |
25,685,745
+4,490,510
| +21% | +$99.2M | 0.02% | 652 |
|
|
2020
Q1 | $475M | Buy |
21,195,235
+1,742,777
| +9% | +$47.7M | 0.02% | 629 |
|
|
2019
Q4 | $573M | Buy |
19,452,458
+690,450
| +4% | +$18.8M | 0.02% | 714 |
|
|
2019
Q3 | $499M | Sell |
18,762,008
-1,721,164
| -8% | -$51.6M | 0.02% | 752 |
|
|
2019
Q2 | $692M | Buy |
20,483,172
+924,059
| +5% | +$30M | 0.03% | 582 |
|
|
2019
Q1 | $627M | Buy |
19,559,113
+16,835,410
| +618% | +$518M | 0.03% | 608 |
|
|
2018
Q4 | $85.9M | Buy |
2,723,703
+1,799,434
| +195% | +$58.9M | ﹤0.01% | 1908 |
|
|
2018
Q3 | $32.2M | Buy |
+924,269
| New | +$32.5M | ﹤0.01% | 2616 |
|
Other funds holding ELAN
BCIM
BlackRock's ELAN Position: Q2 2026 in Review
BlackRock increased its Elanco Animal Health (ELAN) stake by 2.6% in Q2 2026, buying an estimated $28.4M and bringing the position to 48,849,973 shares worth $1.2B. The position accounts for 0.02% of the portfolio, ranked #664.
BlackRock first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- BlackRock held 48,849,973 shares of Elanco Animal Health worth $1.2B as of Q2 2026.
- BlackRock bought 1,227,343 Elanco Animal Health shares in Q2 2026, an estimated $28.4M.
- Elanco Animal Health made up 0.02% of BlackRock's portfolio in Q2 2026, its #664 holding.
- BlackRock first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
- 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.